Third Harmonic Bio, Inc. Contracts & Agreements
18 Contracts & Agreements
- Business Finance (4 contracts)
- Human Resources (7)
- Intellectual Property (1)
- Uncategorized (6)
- Separation Agreement, dated October 24, 2023, by and between the Registrant and Adrian Ray (Filed With SEC on March 26, 2024)
- Offer Letter, dated March 25, 2022, by and between the Registrant and Adrian Ray (Filed With SEC on March 26, 2024)
- Offer Letter, dated May 23, 2022, by and between the Registrant and Julie Person (Filed With SEC on March 26, 2024)
- Form of Common Stock Certificate (Filed With SEC on September 8, 2022)
- Form of Change in Control and Severance Agreement (Filed With SEC on September 8, 2022)
- Amended and Restated Employment Agreement, dated August 22, 2022, by and between the Registrant and Natalie Holles (Filed With SEC on September 8, 2022)
- 2022 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 8, 2022)
- 2022 Equity Incentive Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 8, 2022)
- Form of Indemnity Agreement (Filed With SEC on September 8, 2022)
- Form of Underwriting Agreement (Filed With SEC on September 8, 2022)
- Amended and Restated Investors Rights Agreement, dated December 17, 2021 by and among the Registrant and certain of its stockholders (Filed With SEC on August 23, 2022)
- Consulting and Scientific Advisory Board Agreement, dated July 25, 2019, by and between the Registrant and H. Martin Seidel (Filed With SEC on August 23, 2022)
- Consulting Agreement, dated June 14, 2019, by and between the Registrant and Mark Iwicki (Filed With SEC on August 23, 2022)
- Offer Letter, dated July 2, 2021, by and between the Registrant and Natalie Holles (Filed With SEC on August 23, 2022)
- License Agreement, dated June 28, 2019, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on August 23, 2022)
- Use and Occupancy Agreement, dated July 1, 2021, by and between the Registrant and Atlas Venture Life Science Advisors, LLC (Filed With SEC on August 23, 2022)
- Use and Occupancy Agreement, dated February 1, 2021, by and among the Registrant and Atlas Venture Life Science Advisors, LLC (Filed With SEC on August 23, 2022)
- 2019 Stock Incentive Plan, as amended, and forms of award agreements (Filed With SEC on August 23, 2022)
